These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35390712)

  • 21. Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer.
    Bai C; Wu S; Ren S; Zhu M; Luo G; Xiang H
    Bioorg Med Chem; 2021 May; 37():116107. PubMed ID: 33735799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and mechanism of action of new purine derivatives against triple negative breast cancer.
    Zhang Q; Sun G; Huang Y; Cui S; Li T; Zhao L; Lu K; Yu P; Zhang Y; Galons H; Oumata N; Teng Y
    Eur J Med Chem; 2023 Dec; 261():115797. PubMed ID: 37708799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and anti-TNBC activity of Azeliragon triazole analogues.
    Xie J; Xu H; Wu X; Xie Y; Lu X; Wang L
    Bioorg Med Chem Lett; 2021 Dec; 54():128444. PubMed ID: 34763082
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of mitochondrial apoptotic pathway in triple negative breast carcinoma cells by methylglyoxal via generation of reactive oxygen species.
    Roy A; Ahir M; Bhattacharya S; Parida PK; Adhikary A; Jana K; Ray M
    Mol Carcinog; 2017 Sep; 56(9):2086-2103. PubMed ID: 28418078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
    Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design and Synthesis of Novel Celecoxib Analogues with Potential Cytotoxic and Pro-apoptotic Activity against Breast Cancer Cell Line MCF-7.
    Abdelhaleem EF; Kassab AE; El-Nassan HB; Khalil OM
    Med Chem; 2022; 18(8):903-914. PubMed ID: 35264093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.
    Kumar D; Haldar S; Gorain M; Kumar S; Mulani FA; Yadav AS; Miele L; Thulasiram HV; Kundu GC
    BMC Cancer; 2018 Jan; 18(1):52. PubMed ID: 29310608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhizoma Amorphophalli inhibits TNBC cell proliferation, migration, invasion and metastasis through the PI3K/Akt/mTOR pathway.
    Wu C; Qiu S; Liu P; Ge Y; Gao X
    J Ethnopharmacol; 2018 Jan; 211():89-100. PubMed ID: 28962890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic activity of DCC-2036, a novel tyrosine kinase inhibitor, against triple-negative breast cancer patient-derived xenografts by targeting AXL/MET.
    Shen Y; Zhang W; Liu J; He J; Cao R; Chen X; Peng X; Xu H; Zhao Q; Zhong J; Ding W; Lei X; Jiang Y; Zu X
    Int J Cancer; 2019 Feb; 144(3):651-664. PubMed ID: 30289981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis and biological evaluation of anilide (dicarboxylic acid) shikonin esters as antitumor agents through targeting PI3K/Akt/mTOR signaling pathway.
    Ma Y; Yang X; Han H; Wen Z; Yang M; Zhang Y; Fu J; Wang X; Yin T; Lu G; Qi J; Lin H; Wang X; Yang Y
    Bioorg Chem; 2021 Jun; 111():104872. PubMed ID: 33838560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rubioncolin C, a natural naphthohydroquinone dimer isolated from Rubia yunnanensis, inhibits the proliferation and metastasis by inducing ROS-mediated apoptotic and autophagic cell death in triple-negative breast cancer cells.
    Li L; Wang J; Feng L; Fan J; Wang J; Tan N; Wang Z
    J Ethnopharmacol; 2021 Sep; 277():114184. PubMed ID: 33961996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new oridonin analog suppresses triple-negative breast cancer cells and tumor growth via the induction of death receptor 5.
    Wu J; Ding Y; Chen CH; Zhou Z; Ding C; Chen H; Zhou J; Chen C
    Cancer Lett; 2016 Oct; 380(2):393-402. PubMed ID: 27387452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. INPP4B overexpression enhances the antitumor efficacy of PARP inhibitor AG014699 in MDA-MB-231 triple-negative breast cancer cells.
    Sun Y; Ding H; Liu X; Li X; Li L
    Tumour Biol; 2014 May; 35(5):4469-77. PubMed ID: 24420152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents.
    Xu J; Kim H; Dong J; Chen H; Xu J; Ma R; Zhou M; Wang T; Shen Q; Zhou J
    Eur J Med Chem; 2022 Apr; 234():114229. PubMed ID: 35334447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer.
    Cheng G; Fan X; Hao M; Wang J; Zhou X; Sun X
    Mol Cancer; 2016 Apr; 15(1):30. PubMed ID: 27130446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Anti-TNBC Agents Targeting PTP1B: Total Synthesis, Structure-Activity Relationship,
    Hu C; Li G; Mu Y; Wu W; Cao B; Wang Z; Yu H; Guan P; Han L; Li L; Huang X
    J Med Chem; 2021 May; 64(9):6008-6020. PubMed ID: 33860662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual Inhibition of Key Proliferation Signaling Pathways in Triple-Negative Breast Cancer Cells by a Novel Derivative of Taiwanin A.
    Kuo YH; Chiang EI; Chao CY; Rodriguez RL; Chou PY; Tsai SY; Pai MH; Tang FY
    Mol Cancer Ther; 2017 Mar; 16(3):480-493. PubMed ID: 27956520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells.
    Liu CY; Hu MH; Hsu CJ; Huang CT; Wang DS; Tsai WC; Chen YT; Lee CH; Chu PY; Hsu CC; Chen MH; Shiau CW; Tseng LM; Chen KF
    Oncotarget; 2016 Feb; 7(8):9135-49. PubMed ID: 26824320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginsenoside Rg3 promotes cytotoxicity of Paclitaxel through inhibiting NF-κB signaling and regulating Bax/Bcl-2 expression on triple-negative breast cancer.
    Yuan Z; Jiang H; Zhu X; Liu X; Li J
    Biomed Pharmacother; 2017 May; 89():227-232. PubMed ID: 28231544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.